It improved AOM/DSS-induced microbial dysbiosis, increased the production of short-chain fatty acids, alleviated endotoxemia, and improved intestinal shielding function by inhibiting TLR4/MyD88/NF-κB signaling. The gene discussed is TLR4; the disease is infectious otitis media.